Extended Deep Venous Thrombosis Prophylaxis in Gynecologic Oncology Surgery With Intermittent Compression Devices (ICD) With or Without Postoperative Arixtra [fondaparinux sodium]: A Randomized Controlled Trial.

Trial Profile

Extended Deep Venous Thrombosis Prophylaxis in Gynecologic Oncology Surgery With Intermittent Compression Devices (ICD) With or Without Postoperative Arixtra [fondaparinux sodium]: A Randomized Controlled Trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2012 Actual patient number changed from 8 to 7 as reported by ClinicalTrials.gov.
    • 08 Mar 2012 Planned end date changed from 1 Jun 2011 to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 28 Oct 2010 Planned end date changed from 1 Jun 2008 to 1 Jun 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top